Rituximab as first line treatment for MALT lymphoma of extraocular muscles

被引：15

作者：

Benetatos, Leonidas ^{[1
]}

Alymara, Vasiliki

Asproudis, Ioannis

Bourantas, Konstantinos L.

机构：

[1] Univ Hosp Ionnina, Dept Hematol, Ioannina, Greece

[2] Univ Hosp Ioannina, Dept Ophthalmol, Ioannina, Greece

来源：

ANNALS OF HEMATOLOGY | 2006年 / 85卷 / 09期

关键词：

D O I：

10.1007/s00277-006-0134-0

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

页码：625 / 626

页数：2

共 6 条

[1]

Asproudis I, 2005, IN VIVO, V19, P1105

[2]

Tolerability and safety of rituximab (MabThera®) [J].

Kimby, E .

CANCER TREATMENT REVIEWS, 2005, 31 (06) :456-473

[3]

Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type of the orbit and ocular adnexa [J].

Lee, JL ;

Kim, MK ;

Lee, KH ;

Hyun, MS ;

Chung, HS ;

Kim, DS ;

Shin, SO ;

Cho, HS ;

Bae, SH ;

Ryoo, HM .

ANNALS OF HEMATOLOGY, 2005, 84 (01) :13-18

[4]

Somatostatin receptor scintigraphy in MALT lymphoma of the lacrimal gland treated with rituximab [J].

Morgensztern, D ;

Rosado, MF ;

Serafini, AN ;

Lossos, IS .

LEUKEMIA & LYMPHOMA, 2004, 45 (06) :1275-1278

[5]

Anti-CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctiva [J].

Nückel, H ;

Meller, D ;

Steuhl, KP ;

Dührsen, U .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2004, 73 (04) :258-262

[6]

Ocular adnexal lymphoma:: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci [J].

Rosado, MF ;

Byrne, GE ;

Ding, FY ;

Fields, KA ;

Ruiz, P ;

Dubovy, SR ;

Walker, GR ;

Markoe, A ;

Lossos, IS .

BLOOD, 2006, 107 (02) :467-472

← 1 →